Ligand Pharmaceuticals Inc

Ownership Transactions Reported by 17 Insiders

Symbol
LGND on Nasdaq, LGNDZ, LGNXZ, LGNYZ, LGNZZ on OTC
Location
3911 Sorrento Valley Blvd, Suite 110, San Diego, CA

Insiders trading volume in the past year

Ligand Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John L. Higgins Director $30.2M Dec 28, 2022
Todd C. Davis Chief Executive Officer, Director $12M +$243K +2.07% Aug 8, 2024
Matthew W. Foehr Former Executive Officer $11.7M Nov 1, 2022
Jason Aryeh Director $11.7M Jun 14, 2024
Matthew E. Korenberg President & COO $5.18M -$6.92M -57.2% Sep 20, 2024
John W. Kozarich Director $3.79M Jun 14, 2024
John L. Lamattina Director $3.65M -$298K -7.54% Nov 27, 2024
Octavio Espinoza Chief Financial Officer $2.81M -$1.29M -31.5% Dec 5, 2024
Stephen L. Sabba Director $2.61M -$141K -5.1% Jun 14, 2024
Andrew Reardon CLO & Secretary $2.24M -$1.19M -34.6% Sep 23, 2024
Sunil Patel Former Director $2.08M Nov 1, 2022
Charles S. Berkman Former Executive Officer $1.72M Nov 1, 2022
Nancy Ryan Gray Director $597K -$77.7K -11.5% Jun 14, 2024
Jason Haas Director $468K Jun 14, 2024
Martine Zimmermann Director $306K Jun 14, 2024
Sarah Boyce Former Director $209K Nov 1, 2022
Jennifer R. Cochran Former Director $84K Nov 1, 2022

Recent Insider Transactions by Companies or Individuals for Ligand Pharmaceuticals Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.